Corteva Inc. (CTVA)
NYSE: CTVA
· Real-Time Price · USD
69.59
0.11 (0.16%)
At close: Sep 24, 2025, 3:59 PM
70.27
0.98%
After-hours: Sep 24, 2025, 06:40 PM EDT
Corteva Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biologicals Revenue | 84M | 1.03B | 315M | 2.68B | 2.09B | 1.79B | 878M | 2.67B | 1.98B | 1.33B | 469M | 2.22B | 1.93B | 1.11B | 437M | 2.18B | 1.89B | 958M | 303M | 2.06B | 1.86B | 2.43B | 372M | 2.31B |
| Biologicals Revenue Growth | -91.85% | +227.30% | -88.26% | +28.56% | +16.27% | +104.44% | -67.15% | +35.07% | +48.35% | +184.43% | -78.89% | +15.13% | +73.41% | +154.69% | -79.95% | +15.47% | +97.08% | +216.17% | -85.27% | +10.35% | -23.29% | +553.23% | -83.89% | n/a |
| Fungicides Revenue | 304M | 1.41B | 736M | 946M | 886M | 1.81B | 1.71B | 986M | 1.24B | 1.12B | 1.04B | 1.22B | 1.21B | 1.08B | 782M | 969M | 986M | 965M | 583M | 909M | 823M | 1.64B | 584M | 1.04B |
| Fungicides Revenue Growth | -78.45% | +91.71% | -22.20% | +6.77% | -50.94% | +5.49% | +73.63% | -20.61% | +10.99% | +7.29% | -14.79% | +1.58% | +11.78% | +37.85% | -19.30% | -1.72% | +2.18% | +65.52% | -35.86% | +10.45% | -49.88% | +181.16% | -44.06% | n/a |
| Herbicides Revenue | 860M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Herbicides Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Insecticides Revenue | 336M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Insecticides Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Revenue | 126M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Crop Protection Revenue | 1.71B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Crop Protection Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Seed Revenue | 2.71B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Seed Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2019 |
|---|---|
| Asia Pacific Revenue | 1.46B |
| Asia Pacific Revenue Growth | n/a |
| Emea Revenue | 2.11B |
| Emea Revenue Growth | n/a |
| Latin America Revenue | 469M |
| Latin America Revenue Growth | n/a |
| United States Revenue | 2.25B |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.16B | 751M | 626M | 708M | 1.05B | 736M | 644M | 700M | 1.07B | 757M | 764M | 657M | 1.02B | 735M | 806M | 672M | 998M | 733M | 724M | 597M | 965M | 757M | 747M | 646M | 937M | 735M | 555M | 633M | 965M | 959M | 643M | 668M | 830.5M | 830.5M |
| Selling, General, and Administrative Revenue Growth | +53.93% | +19.97% | -11.58% | -32.83% | +43.21% | +14.29% | -8.00% | -34.88% | +42.01% | -0.92% | +16.29% | -35.40% | +38.37% | -8.81% | +19.94% | -32.67% | +36.15% | +1.24% | +21.27% | -38.13% | +27.48% | +1.34% | +15.63% | -31.06% | +27.48% | +32.43% | -12.32% | -34.40% | +0.63% | +49.14% | -3.74% | -19.57% | 0.00% | n/a |
| Research and Development Revenue | 375M | 335M | 365M | 348M | 357M | 332M | 357M | 335M | 329M | 316M | 340M | 312M | 296M | 268M | 316M | 297M | 293M | 281M | 305M | 284M | 273M | 280M | 290M | 289M | 269M | 355M | 379M | 325M | 354M | 382M | 383M | 387M | 369.5M | 369.5M |
| Research and Development Revenue Growth | +11.94% | -8.22% | +4.89% | -2.52% | +7.53% | -7.00% | +6.57% | +1.82% | +4.11% | -7.06% | +8.97% | +5.41% | +10.45% | -15.19% | +6.40% | +1.37% | +4.27% | -7.87% | +7.39% | +4.03% | -2.50% | -3.45% | +0.35% | +7.43% | -24.23% | -6.33% | +16.62% | -8.19% | -7.33% | -0.26% | -1.03% | +4.74% | 0.00% | n/a |